Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Aurobindo
Aurobindo
Activities:
Ingredients
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Pharmaceutical
Indian pharma firms develop niche portfolios
They aim to take advantage of generic growth in the US over the next two years
Pharmaceutical
Indian generic manufacturers aim to enter the Japanese market
The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Media
Aurobindo's generic drug for osteoporosis approved by US FDA
The global osteoporosis drugs market is seeing significant growth due to a rising geriatric population and changing lifestyles
Finance
Aurobindo and Glenmark to get inflow of foreign capital
Deals underscore the importance given by the Indian government to strengthening healthcare in the country, by ensuring availability of drugs to the population at reasonable prices
Finance
Aurobindo divests stake in Australian subsidiary
Company also reaches settlement with Plethico over Natrol acquisition
Regulatory
Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis
The capsules were manufactured at two plants in India
You need to be a subscriber to read this article.
Click here
to find out more.
Research & Development
Syntheses that cut costs and boost yields
Reworking drug syntheses using cheaper or more environmentally friendly ingredients and catalysts can increase margins dramatically. Dr Sarah Houlton reports on recent successes
Subscribe now